The New Bacteria Expressing Recombinant Multi-epitope Vaccine againstHelicobacter pylori and ItsMicrobiological Characteristics

WANG Bao-ning, PAN Xing, HUANG Xiao-jun. et al

Abstract

To construct the engineering bacteria with recombinant plasmid expressing the multi-epitope vaccine which composed of Helicobacter pylori urea membrane channel protein (UreI), Helicobacter pylori urease B subunit (UreB) and cholera toxin B subunit (CTB), and then to study it’s microbiological characteristics. Methods The sequence contains some dominant epitopes of Helicobacter pylori UreI and UreB was designed, and ctB was added at the N-terminal, all the sequence were linked by flexible linkers. Codon optimization was done according to Escherichia coli (E.coli) BL21 (DE3) bias, the optimized sequence was designated BIB. BIB sequence was synthesized and cloned into plasmid pET28a(+). The recombinant plasmid was confirmed by restriction enzyme digestion and DNA sequencing. The recombinant protein BIB was expressed in E.coli BL21 (DE3) and analyzed by Western blot. Results The plasmid of pET28a(+)/BIB was constructed successfully, confirmed by restriction enzyme digestion and DNA sequencing. The recombinant protein BIB with relative molecular mass about 33×103 could be produced by E.coli BL21 (DE3) and was detected by Western blot. The relative molecular mass and N-terminal amino acid sequence of BIB were 100% identity with the design. Conclution The engineering bacteria with recombinant plasmid expressing the multi-epitope vaccine against Helicobacter pylori was constructed successfully. The recombinant protein BIB can be identified by anti-Sydney strain 1 of Helicobacter pylori (H. pylori SS1) polyclonal antibody and anti-CTB monoclonal antibody, which demonstrated that BIB has the expected antigenicity.

 

Keywords: Helicobacter pylori, Multi-epitope vaccine, Urease B subunit, Urease I subunit, Cholera toxin, B subunit 

 

Full Text:

PDF


References


Zhang L, Yang Y, Yang X, et al. T cell epitope-based peptide- DNA dual vaccine induces protective immunity against Schistosoma japonic uni infection in C57BL 6J mice. Microbes Infect,2008; 10(3) :251-259.

Goldstein G, Chicca JJ 2nd. A universal anti-HIV-1 Tat epitope vaccine that is fully synthetic and self-adjuvanting. Vaccine,2010;28(4) : 1008-1014.

Chen L, Li B. Yang WC, et al. A dominant CD4 + T-cell response to Helicobacter pylori reduces risk for gastric disease in humans. Gastroenterology ,2013 ; 144(3) :591-600.

Del Giudice G, Malfertheiner P. Rappuoli R. Development of vaccines against Helicobacter pylori. Expert Rev Vaccines, 2009;8(8):1037-1049.

Shi Y, Liu XF, Zhuang Y. et al. Helicobacter pylori-induced Till7 responses modulate Thl cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol,2010; 184(9):5121-5129.

Zhou WY, Shi Y, WuC, et al. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/ с mice model. Vaccine,2009;27(36);5013-5019.

Wang В. Pan X, Wang H, et al. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies. Int J Clin Exp Pathol, 2014 ; 7 ( 10 ) : 6559-6566.

Kusters JG, van Vliet AHM. Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev, 2006; 19 (3): 449-490.

Figura N, Franceschi F, Santucci A, et al. Extragastric manifestations of Helicobacter pylori infection. Helicobacter, 2010; 15(Suppl 1) :60-68.

Smythies LE, Novak MJ, Waites KB, et al. Poliovirus replicons encoding the В subunit of Helicobacter pylori urease protect mice against H. pylori infection. Vaccine,2005;23(7): 901-909.

Gray LR, Gu SX, Quick M, et al. Transport kinetics and selectivity of HpUrel, the urea channel from Helicobacter pylori. Biochemistry,2011;50(40);8656-8663.

Areas АРМ, Oliveira MLS. Miyaji EN, et al. Expression and characterization of cholera toxin B-pneumococcal surface adhesin A fusion protein in Escherichia coli: ability of CTB- PsaA to induce humoral immune response in mice. Biochem Bioph Res Co,2004; 321 (1): 192-196.

Wang BN, Yang J, Cao SZ, et al. Preparation of specific anti- Helicobacter pylori yolk antibodies and their antibacterial effects. Int J Clin Exp Pathol,2014;7( 10);6430-6437.


Refbacks

  • There are currently no refbacks.